A pipeline of novel, disease-modifying drugs
Our RNA therapeutic drugs are splice-switching oligonucleotides (SSOs) that up-regulate a naturally occurring, anti-inflammatory spliceoform of RAGE ('esRAGE') in inflamed tissues.
Our peptide drugs block pro-inflammatory signalling from activated RAGE in inflamed tissue.
